We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$325B
AUM Growth
+$19.8B
Cap. Flow
+$3.2B
Cap. Flow %
0.99%
Top 10 Hldgs %
12.37%
Holding
6,814
New
216
Increased
2,666
Reduced
3,277
Closed
152

Sector Composition

Rank Sector Weight
1 Financials 9.69%
2 Technology 9.44%
3 Healthcare 8.03%
4 Consumer Discretionary 7.35%
5 Communication Services 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCLP
5351
DELISTED
CSI Compressco LP
CCLP
$144K ﹤0.01%
14,624
-49,185
-77% -$525K
NYMX
5352
DELISTED
Nymox Pharmaceutical Corp
NYMX
$144K ﹤0.01%
39,396
+30,749
+356% +$101K
NGVC icon
5353
Vitamin Cottage Natural Grocers
NGVC
$739M
$143K ﹤0.01%
13,728
-14,685
-52% -$175K
FMK
5354
DELISTED
First Trust Mega Cap AlphaDEX Fund
FMK
$143K ﹤0.01%
4,881
-1,584
-25% -$46.2K
FUNC icon
5355
First United
FUNC
$285M
$142K ﹤0.01%
9,759
+2,001
+26% +$28.8K
EUHY
5356
iShares Euro High Yield Corporate Bond USD Hedged ETF
EUHY
$240M
$141K ﹤0.01%
3,011
-1,205
-29% -$56.3K
WLYB icon
5357
John Wiley & Sons Class B
WLYB
$2.71B
$141K ﹤0.01%
2,600
MDVL
5358
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$141K ﹤0.01%
81
+68
+523% +$125K
AST
5359
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$141K ﹤0.01%
41,562
-33,503
-45% -$130K
HISF icon
5360
First Trust Exchange-Traded Fund IV First Trust High Income Strategic Focus ETF
HISF
$98.4M
$140K ﹤0.01%
+2,755
New +$140K
PZE
5361
DELISTED
Petrobras Argentina S A
PZE
$140K ﹤0.01%
12,594
-19,219
-60% -$180K
NJV
5362
DELISTED
Nuveen New Jersey Municipal Value Fund Common shares of beneficial interest
NJV
$140K ﹤0.01%
9,458
+3,676
+64% +$57.4K
TZOO icon
5363
Travelzoo
TZOO
$74.3M
$139K ﹤0.01%
14,426
-15,563
-52% -$145K
VIRX
5364
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$139K ﹤0.01%
974
+862
+770% +$123K
ROX
5365
DELISTED
Castle Brands, Inc.
ROX
$139K ﹤0.01%
+89,497
New +$82.4K
SGM
5366
DELISTED
Stonegate Mortgage Corporation
SGM
$139K ﹤0.01%
17,427
+4,036
+30% +$29.6K
PLSE icon
5367
Pulse Biosciences
PLSE
$2.43B
$138K ﹤0.01%
+6,740
New +$91.7K
TSBK icon
5368
Timberland Bancorp
TSBK
$348M
$138K ﹤0.01%
6,156
+1,037
+20% +$22K
CYTO
5369
DELISTED
Altamira Therapeutics Ltd
CYTO
$138K ﹤0.01%
+2
New +$160K
POPE
5370
DELISTED
Pope Resources Depositary Receipts of Limited Partnership Units
POPE
$138K ﹤0.01%
1,954
-2,001
-51% -$138K
NATR icon
5371
Nature's Sunshine
NATR
$354M
$137K ﹤0.01%
13,708
-23,052
-63% -$268K
STPP
5372
DELISTED
iPath US Treasury Steepener ETN
STPP
$137K ﹤0.01%
3,929
-94
-2% -$3.27K
GUSH icon
5373
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X ETF
GUSH
$255M
$135K ﹤0.01%
38
+29
+322% +$121K
RCKT icon
5374
Rocket Pharmaceuticals
RCKT
$340M
$135K ﹤0.01%
16,858
+1,953
+13% +$13.1K
RNAC icon
5375
Cartesian Therapeutics
RNAC
$229M
$135K ﹤0.01%
314
-184
-37% -$77.4K

Similar funds

Morgan Stanley's Q1 2017 Portfolio in Review

As of Q1 2017, Morgan Stanley held 6,814 positions worth $325B, up 6.5% from $306B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Morgan Stanley's Q1 2017 filing shows 216 new, 2,666 increased, 3,277 reduced and 152 closed positions. Its largest new stake was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M. The largest sale was St Jude Medical, an estimated $538M.

By sector, the portfolio is most concentrated in Financials at 9.7% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.

  • Morgan Stanley's largest Q1 2017 buy was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M.
  • Morgan Stanley added most to KKR & Co in Q1 2017, an estimated $705M increase.
  • Morgan Stanley's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $397M.
  • Morgan Stanley fully exited St Jude Medical in Q1 2017, selling an estimated $538M.
  • Morgan Stanley's ten largest holdings make up 12% of its $325B portfolio in Q1 2017.
  • Morgan Stanley opened 216 new positions and closed 152 in Q1 2017.
  • Morgan Stanley's portfolio value rose 6.5% quarter-over-quarter to $325B.

Based on Morgan Stanley's 13F filing for Q1 2017, filed 12 May 2017.